Synedica Retatrutide 40mg Pen
99.0%
40mg
40 mg Retatrutide triple-incretin pen by Synedica — maximum strength fat-loss research peptide. Refrigerate. For research use only
Technical specifications
Molecular formula
-
Purity
99.0%
Storage
-20°C, dark
CAS Number
2381089-83-2
Molecular weight
4731.33 g/mol
Reconstitution
-
Research applications
- For research use only
Not for human consumption, veterinary, or diagnostic use. Handled by qualified researchers only.
Description
Synedica Retatrutide 40mg Pen— Advanced Triple-Incretin Formula
High-dose Synedica Retatrutide 40mg Pen activating GLP-1, GIP and Glucagon receptors for maximum metabolic research impact.
Concentration & Quality
- 40 mg Retatrutide per prefilled pen
- Triple hormone pathway activation
- Synedica pharmaceutical quality standard
Key Features
- Highest dose Retatrutide pen for advanced research
- Targets GLP-1, GIP, and Glucagon receptors simultaneously
- Extended duration of action for long-term studies


